US Stock MarketDetailed Quotes

ACET Adicet Bio

Watchlist
  • 1.630
  • -0.020-1.21%
Close May 9 16:00 ET
  • 1.590
  • -0.040-2.45%
Pre 08:00 ET
133.94MMarket Cap-492P/E (TTM)

About Adicet Bio Company

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Company Profile

SymbolACET
Company NameAdicet Bio
Listing DateJan 26, 2018
Issue Price15.00
Founded2014
CEOMr. Chen Schor, M.B.A.
MarketNASDAQ
Employees143
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address131 Dartmouth Street,3rd floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02116
Phone1-650-503-9095
Websitehttp://www.adicetbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Chen Schor, M.B.A.
  • Chief Executive Officer, President and Director
  • 3.99M
  • Don Healey
  • Chief Technology Officer
  • --
  • Nick Harvey
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Francesco Galimi, M.D.,PhD
  • Chief Medical Officer
  • 1.99M
  • Dr. Blake Aftab
  • Chief Scientific Officer
  • 2.48M
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • 218.87K
  • Dr. Jeffrey A. Chodakewitz, M.D.
  • Independent Director
  • 183.87K
  • Dr. Aya Jakobovits, PhD
  • Independent Director
  • 183.87K
  • Katie Peng
  • Independent Director
  • --
  • Steve Dubin, J.D.
  • Independent Director
  • 197.87K
  • Dr. Michael Glen Kauffman, M.D.,PhD
  • Independent Director
  • 182.87K
  • Dr. Andrew Sinclair, PhD
  • Independent Director
  • 194.37K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg